Study of AT-777 in Healthy Subjects and AT-777 in Combination With AT-527 in HCV-Infected Subjects

NCT04309734 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Withdrawn prior to study initiation.

Conditions

Hepatitis C
Hepatitis C, Chronic
Chronic Hepatitis C
Hepatitis C Virus Infection
HCV Infection

Interventions

DRUG: AT-777
DRUG: Placebo
DRUG: AT-527

Sponsor

Atea Pharmaceuticals, Inc.